No Data
The medical device notification for the biological cleaning device developed jointly with Funpep-Science has been completed.
Fan Pep <4881> announced on the 31st that its consolidated subsidiary, Fan Pep Health Care (FPHC), has developed a biological cleansing device using the science of fine bubble technology called 'MiraBelle Technology' and has completed the notification for manufacturing and sales as a medical device. FPHC has been developing the next generation of biological cleansing devices in collaboration with Science. Notification number: 26B2X10045000001, sales name: MiraBelle Body Washer. In the future, FPHC will continue to develop
Emerging markets stock digest: AVILEN surged significantly, with Immune Biosciences hitting the limit up.
Stalemate. On the 11th, after the close of trading, the performance for the fiscal year ending August 2024 was announced, and it has been in a stalemate even after starting to rise.
Hot stocks digest (morning session): JINSHD, KOZAIDOH HD, Bic Camera, etc.
Cosmos Pharmaceuticals <3349>: ¥7,729 (+¥409) rebounded significantly. The company announced its first-quarter financial results last weekend, with an operating profit of ¥11.6 billion, a 28.8% increase from the same period last year, exceeding the market consensus by approximately ¥2 billion. The gross profit margin for general food has shown significant improvement. The unchanged full-year plan is ¥31.6 billion, a 0.3% increase from the previous year, with a significant upside potential. Additionally, the same-store sales for September that were simultaneously announced decreased by 4.2% compared to the same month last year.
Volume change rate ranking (9 o'clock) - Marumae, Kosaido HD, etc. ranked in.
In the volume change rate ranking, by comparing the average volume of the recent 5 days with the volume on the delivery day, you can understand the interests of market participants such as trends in stockpicking. ■ Volume Change Rate Top [As of 9:32 on October 15] (Comparison of average volume of the recent 5 days) Stock Code Stock Name Volume 5-Day Average Volume Volume Change Rate Stock Price Change Rate <2524> NZAM TPX 111,390 107,185.08 336.99% 0.00
Fanpep---Daiichi Sankyo initiates joint research on a new adjuvant for antibody-guided peptides.
Fan Pep <4881> announced on the 11th that it has started a joint research with Shionogi <4507> on a novel adjuvant for antibody-inducing peptides. Antibody-inducing peptides are peptide therapeutic vaccines that are expected to have therapeutic effects by inducing antibody production against target proteins in the patient's body. Adjuvants are substances used to enhance the effect when administered together with a vaccine for vaccination. The company has functional peptide 'AJP0'.
Shikigaku, the Institute of Immunobiology, and others [Emerging Markets Press Release]
<138A> Hikari Food Service downward revision, this term's operating profit outlook 20.2 billion yen ← 31.2 billion yen <2981> Lendix subsidiary established and new business initiated <4570> Immunobiology Research Institute acquires patent for 'Anti-HIV antibody and method of manufacturing' <4881> Roche initiates joint research with Fanpep on vaccine adjuvant for antibody-directed peptide <5591> Avilen engages in entrusted development of AI-related systems such as LangCo
No Data
No Data